Navigation Links
Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
Date:3/4/2008

in the Company's Form 10-K for the fiscal year ended

December 31, 2006

Vermillion, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(In Thousands, Except Per Share Amounts)

(Unaudited)

Three Months Ended Year Ended

December 31, December 31,

2007 2006 2007 2006

Revenue $23 $1,216 $44 $18,215

Cost of revenue 13 506 28 9,338

Gross profit 10 710 16 8,877

Operating expenses:

Research and

development 1,916 2,693 8,213 11,474

Sales and marketing 735 1,916 2,175 12,568

General and

administrative 2,232 3,112 10,858 10,661

Total operating expenses 4,883 7,721 21,246 34,703

Gain on sale of

instrument business 1,992 6,929 1,610 6,929

Loss from operations (2,881) (82) (19,620) (18,897)

Loss on extinguishment

of debt - (1,481) - (1,481)

Interest and other

expense, net (247) (326) (1,499) (1,536)

Loss before income

taxes (3,128) (1,889) (21,119) (21,914)

Income tax benefit

(expense) (164) 38 (163) (152)

Net loss $(3,292) $(1,851) $(21,282) $(22,066)

Loss per share -

basic and diluted (1) $(0.52) $(0.49) $(4.47) $(6.05)

Shares used to

compute basic and

diluted loss per

common sha
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
10. Access Highlighted in Recent BusinessWeek Article
11. ChemoCentryx Demonstrates Recently Discovered Chemokine Receptor CXCR7 is Essential in Tumor Growth

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...d,November24/PRNewswire-FirstCall/--deCODE,genetic...lofits,"firstday"motionsbytheU.S.BankruptcyCourtfo...DElastweekfiledavoluntarypetitionfor,reliefunderCh...ruptcyCourt. , TheordersissuedbytheBankruptcy...sduringtheChapter11proceedings.Inparticular,the,co...
(Date:11/24/2009)...Nov.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasda...pingandcommercializingnovelpainmanagementtherapies...fExecutiveOfficer,isscheduledtopresentatthe21stAnn...er1-2,2009atTheNewYorkPalaceHotelinNewYork,NewYork...alOfficer,willbeavailabletorespondtoquestionsdurin...
(Date:11/24/2009)...RNewswire/--BlueMarbleEnergyCorp.announcedtodaytha...OPDA)wererecentlyawarded$2millionbyWashingtonState...vate/publicpartnershiptoconstructthestate,sfirstsp..., "Thisinvestmentwillsignificantlyspeedthedevel...colnCounty,"saidBlueMarbleEnergyCEOKellyOgilvie."W...
(Date:11/24/2009)...ndpointhasbeenmetforpatientswithadvanced-stage,orr...4/PRNewswire-FirstCall/-AEternaZentarisInc.(NASDAQ...ticalcompanyfocusedonendocrinetherapyandoncology,t...ithitstargetedcytotoxicpeptideconjugate,AEZS-108(f...dometrialcancer.Inapersonalizedhealthcareapproach,...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4
...covered 125 years ago and dismissed by many biolog...a key role in the process of cytokinesis, or cell ... all biological phenomena. , ,The discovery of the...n this structure - which are necessary for normal ...niversity of Wisconsin-Madison geneticist was anno...
...for 10 years in tax credits , ,MADISON The futur...as discussed at an economic development breakfast ...UW-Madison Small Business Development Center at th...vestment specialists, from both the public and pri...-credit legislation, Act 255. , ,State Secretary o...
...ares poorly when it comes to attracting federal do...es in the bottom five in getting a return on the f... In bringing home the bacon, Wisconsin is mostly o...ederal programs where Wisconsin research instituti...mpete on merit rather than the size of the states ...
Other Biology Technology:UW-Madison scientists find a key to cell division 2UW-Madison scientists find a key to cell division 3The impact of ACT 255 on the future of high-tech investment in Wisconsin 2Heres one federal program where Wisconsin has gained some hard-earned ground 2Heres one federal program where Wisconsin has gained some hard-earned ground 3
(Date:11/23/2009)...NE, Calif. -- More than 160 participants gathered ...s Keck FUTURES INITIATIVE conference. This year,s ...tists, engineers, and medical researchers to explo...surrounding the emerging field of synthetic biolog...iology at Princeton University and this year,s con...
(Date:11/23/2009)...ES, Iowa - The only swine vaccine available for th...rd infected with the virus. The vaccination marks ...rd diagnosed with the pandemic flu., Iowa State ...nce, developed the vaccine this summer and has bee...Iowa, Kansas and Illinois for several weeks., Th...
(Date:11/23/2009)...BIRMINGHAM, Ala. A new study by University of Ala...dy-mass index (BMI) and co-existing medical condit...urvival observed among African-Americans compared ...y is published online Nov. 23 in Cancer , a journ... indicates that although BMI and co-morbidity are ...
Breaking Biology News(10 mins):Synthetic biology offers new opportunities for interdisciplinary collaboration 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Racial disparity in colon cancer survival not easily explained, UAB researchers say 2New Positron Emission Tomography 28PET 29 Biomarker NVB 64 Visualizes Malignant Breast Tumors 5838 1New Positron Emission Tomography 28PET 29 Biomarker NVB 64 Visualizes Malignant Breast Tumors 5838 2New Positron Emission Tomography 28PET 29 Biomarker NVB 64 Visualizes Malignant Breast Tumors 5838 3U M study uncovers key to how triggering event in cancer occurs 60341 1U M study uncovers key to how triggering event in cancer occurs 60341 2Kaiser Permanente gives 245 2 million to endow Center for Health Equity at UCLA 60338 1Kaiser Permanente gives 245 2 million to endow Center for Health Equity at UCLA 60338 2
...ngle crafty protein allows the deadly bacterium S...e intestine and hijack cellular functions to avoid... 17 issue of the journal Cell . , This evolution...hal tricks of Salmonella , which kills more than ..., this hijacking of cellular machinery to diversif...
...ntists at Singapore,s Institute of Bioengineering ...ng the potential of carbon dioxide a common green...duct. , In the international chemistry journal ...t by using organocatalysts, they activated carbon ... methanol, a widely used industrial feedstock and ...
...INNATIUniversity of Cincinnati (UC) cancer cell bi... increased lung cancer susceptibility and developm...in a genetic predisposition to develop lung cancer...sease. , With further investigation, they believ...ients who may benefit from earlier, more aggressiv...
Other Biology News:Yale researchers uncover secrets of salmonella's stealth attack 2Singapore researchers first to transform carbon dioxide into methanol 2Researchers identify specific lung cancer susceptibility gene 2
Chromosomal Grade Agarose from Bio-Rad
DNA Engine Dyad Thermal Cycler Chassis from Bio-Rad
TRAPEZE® RT Telomerase Detection Kit from CHEMICON
Experion Pro260 Analysis Kit for 10 Chips from Bio-Rad
Biology Products: